| |
| |
|
| Insider
Information: |
Roach James M. |
| Relationship: |
Senior VP, Development... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
155,381 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,154,395 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
155,381 |
|
|
| Total
Value |
$8,154,395 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
Senior VP, Development... |
2016-11-22 |
155,381 |
2009-02-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2016-11-22 |
4 |
AS |
$14.40 |
$3,600 |
D/D |
(250) |
155,381 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2016-11-21 |
4 |
AS |
$13.45 |
$11,311 |
D/D |
(841) |
155,631 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2016-08-22 |
4 |
AS |
$12.10 |
$3,013 |
D/D |
(249) |
156,472 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2016-08-19 |
4 |
AS |
$12.04 |
$10,138 |
D/D |
(842) |
156,721 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2016-05-20 |
4 |
AS |
$10.11 |
$2,528 |
D/D |
(250) |
157,563 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2016-05-19 |
4 |
AS |
$10.20 |
$8,588 |
D/D |
(842) |
157,813 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2016-04-18 |
4 |
D |
$9.69 |
$60,136 |
D/D |
(6,206) |
158,655 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2016-04-13 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
164,861 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2016-02-22 |
4 |
AS |
$9.65 |
$2,413 |
D/D |
(250) |
104,861 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2016-02-19 |
4 |
AS |
$9.64 |
$20,807 |
D/D |
(2,158) |
105,111 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2016-02-18 |
4 |
AS |
$10.49 |
$2,853 |
D/D |
(272) |
107,269 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2016-02-09 |
4 |
S |
$0.00 |
$0 |
D/D |
(17,100) |
107,541 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-11-20 |
4 |
AS |
$17.75 |
$6,390 |
D/D |
(360) |
90,441 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-11-19 |
4 |
AS |
$18.17 |
$10,957 |
D/D |
(603) |
90,801 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-11-17 |
4 |
AS |
$17.65 |
$5,507 |
D/D |
(312) |
91,404 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-08-20 |
4 |
AS |
$22.20 |
$8,059 |
D/D |
(363) |
91,716 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-08-19 |
4 |
AS |
$22.00 |
$154,883 |
D/D |
(7,011) |
92,079 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-08-18 |
4 |
AS |
$21.81 |
$141,765 |
D/D |
(6,500) |
99,090 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-08-17 |
4 |
AS |
$21.67 |
$6,761 |
D/D |
(312) |
105,590 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-06-18 |
4 |
AS |
$23.70 |
$592,500 |
D/D |
(25,000) |
105,902 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-06-18 |
4 |
OE |
$7.41 |
$185,250 |
D/D |
25,000 |
130,902 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-06-01 |
4 |
AS |
$21.70 |
$542,500 |
D/D |
(25,000) |
105,902 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-06-01 |
4 |
OE |
$7.41 |
$185,250 |
D/D |
25,000 |
130,902 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-05-20 |
4 |
AS |
$19.68 |
$7,085 |
D/D |
(360) |
105,902 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-05-19 |
4 |
AS |
$19.63 |
$12,112 |
D/D |
(617) |
106,262 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
